Reagentless blood analysis by near-infrared Raman spectroscopy

Diabetes Technol Ther. 1999 Summer;1(2):153-7. doi: 10.1089/152091599317369.

Abstract

Background: Raman spectroscopy has advantages over infrared absorption spectroscopy. Combined with a novel multivariate technique, hybrid linear analysis (HLA), low prediction error is expected.

Methods: A near-infrared (NIR) light source excited Raman signals, and a charge coupled device (CCD) camera was used to collect the signal. Samples were collected from 69 individuals for 7 weeks. The standard multivariate calibration technique, partial least squares (PLS) and HLA were both used to analyze the collected spectra. A Clarke error grid was used to evaluate the usefulness of the glucose measurement in serum.

Results: The root mean squared error of prediction (RMSEP) for glucose in serum obtained with PLS is 21 mg/dL, and the RMSEP obtained with HLA is 17 mg/dL. In whole blood, the PLS RMSEP for glucose was 79 mg/dL, and HLA predictions had an RMSEP of 63 mg/dL.

Conclusions: The measurement technique was robust over the 7-week period. HLA was shown to generate a lower prediction error than PLS. The predictions by both PLS and HLA were clinically acceptable. The result with whole blood requires further improvement.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Blood Chemical Analysis / instrumentation
  • Blood Chemical Analysis / methods*
  • Blood Glucose / analysis*
  • Calibration
  • Humans
  • Least-Squares Analysis
  • Multivariate Analysis
  • Reproducibility of Results
  • Spectrum Analysis, Raman / instrumentation*
  • Spectrum Analysis, Raman / methods*

Substances

  • Blood Glucose